davidrliu Profile Banner
David R. Liu Profile
David R. Liu

@davidrliu

Followers
73K
Following
10K
Media
663
Statuses
3K

Professor at Harvard, Broad Institute, & HHMI. Our lab integrates chemistry & evolution to illuminate biology & enable new therapeutics. IG/Threads: @davidrliu1

Massachusetts, USA
Joined November 2008
Don't wanna be here? Send us removal request.
@davidrliu
David R. Liu
1 month
Today in @CellCellPress we report the use of prime editing to correct several mutations that cause alternating hemiplegia of childhood (AHC), a rare and devastating neurodevelopmental disorder, in patient-derived cells and in two mouse models. 1/10
Tweet media one
14
132
680
@davidrliu
David R. Liu
14 days
A wonderful article by @DhruvKhullar on patients with progeria, the genetics behind this rare disease, and our ongoing efforts with PRF and @NIH to advance promising base editing outcomes in humanized progeria mice into a clinical trial.
Tweet card summary image
newyorker.com
Teen-agers with progeria have effectively aged eight or nine decades. A cure could help change millions of lives—and shed light on why we grow old.
3
53
231
@grok
Grok
6 days
What do you want to know?.
478
310
2K
@davidrliu
David R. Liu
25 days
Data from the second human treated with a prime edited medicine: a 56-year-old male with chronic granulotamous disease (CGD) had his bone marrow prime edited to insert the missing GT in NCF1, restoring NADPH oxidase function in neutrophils (DHR positivity) several fold beyond the
Tweet media one
17
136
638
@davidrliu
David R. Liu
1 month
RT @EricTopol: One-shot prime genome editing ("CRISPR 3.0") of the brain in vivo corrected AHC, a rare genetic disorder, in the mouse model….
Tweet card summary image
cell.com
Prime editing and base editing in mouse models and human cells effectively correct mutations in a gene that causes a childhood neurodevelopmental disorder called alternating hemiplegia of childhood....
0
59
0
@davidrliu
David R. Liu
1 month
Research towards potential clinical use is underway. This work was co-led by @AlexanderASousa, @HoltSakai, and Markus Terrey and co-directed with Cat Lutz, in a wonderful collaboration of @broadinstitute, @jacksonlab, @RAREH0pe, @NorthwesternU, @MassGenBrigham, @UMassChan.
1
1
30
@davidrliu
David R. Liu
1 month
These results represent the first use of prime editing to rescue a neurological disease in animals, establish that in vivo postnatal intervention in AHC’s pathology is possible, and suggest the potential of a one-time prime editing treatment for AHC. (Photo:
Tweet media one
1
6
48
@davidrliu
David R. Liu
1 month
In addition to the rescue of behavioral deficits, we also observed large long-term survival improvements in prime editor-treated AHC mice compared with their vehicle-treated counterparts. Indeed, the majority of all four PE-treated mouse cohorts were still alive at the time of
Tweet media one
1
0
12
@davidrliu
David R. Liu
1 month
Prime editor-treated D801N (blue) and E815K (orange) AHC mice showed extensive rescue of multiple patient-relevant behavioral phenotypes, including rescue of rotarod-measured coordination to wild-type levels and near-elimination of trigger-induced seizures. 7/10
Tweet media one
Tweet media two
1
0
10
@davidrliu
David R. Liu
1 month
A single 1.1e11 vg/mouse P0 ICV injection of AAV9 encoding the prime editor into the brain resulted in up to 48% DNA and 73% mRNA correction in bulk cortex and rescued hippocampal Atp1a3 ATPase activity from ~50% to 77%–87% of wild-type activity in treated AHC mice. 6/10
Tweet media one
2
0
13
@davidrliu
David R. Liu
1 month
Next we performed in vivo brain prime editing in two AHC mouse models (Markus Terrey, Cat Lutz, et al. @jacksonlab, PMID: 40381892). Both mouse models show key AHC features: motor/cognitive defects, paroxysmal attacks, reduced lifespan and weight, and Atp1a3 ATPase defects. 5/10
Tweet media one
1
0
14
@davidrliu
David R. Liu
1 month
Genome-wide off-target analysis in patient-derived iPSCs detected minimal off-target editing, especially for PE and for the ABE8e-V106W or ABE7.10 variants of base editors. No off-target edits were found in exons, UTRs, splice junctions or promoters. 4/10
Tweet media one
1
0
13
@davidrliu
David R. Liu
1 month
To directly address the genetic cause of AHC, we developed prime editing and base editing strategies to correct five ATP1A3 mutations, including the four most prevalent variants, with 43%–90% efficiency in AHC patient-derived iPSCs. 3/10
Tweet media one
1
0
13
@davidrliu
David R. Liu
1 month
Most AHC cases are caused by mutations in ATP1A3, which encodes a sodium pump essential for neuron function. These mutations often have a dominant-negative effect; indeed, we observed that ATP1A3 gene addition in AHC mice did not improve behavioral phenotypes or survival. 2/10
Tweet media one
1
1
16
@davidrliu
David R. Liu
2 months
RT @LEXPRESS: 💬 "L’humanité pourra bientôt agir sur son destin génétique". Le scientifique américain @davidrliu (@Harvard) a révolutionné l….
Tweet card summary image
l.lexpress.fr
Ce scientifique américain a révolutionné les technologies d’édition du génome. En réécrivant l’ADN, ses "machines moléculaires" sauvent déjà des vies.
0
7
0
@davidrliu
David R. Liu
2 months
RT @brkthroughprize: The Gene Editor: 2025 Breakthrough Prize winner David Liu introduces base editing and prime editing, the transformativ….
0
11
0
@davidrliu
David R. Liu
2 months
RT @broadinstitute: Gene editing pioneer @davidrliu discusses baby K.J. Muldoon, the first person treated with a customized gene editing th….
0
53
0
@davidrliu
David R. Liu
2 months
A preprint from @nataliyakosmyna and coworkers reports EEG evidence that writing using LLMs reduces neural connectivity and cognitive engagement compared to unaided writing or using standard search engines. Persistent use of LLMs weakened cognitive activation and impaired memory.
7
29
151